Gujarat Themis Biosyn Limited (GUJTHEM) — Insider Trading
Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares from Pharmaceutical Business Group (India) Limited at Rs. 395.75 per share, totaling up to Rs. 20 crores, representing 0.50% of the company's share capital. The transaction, scheduled between 08.07.2026 and 14.07.2026, is an inter-se transfer among promoters and complies with SEBI takeover exemption norms. Post-acquisition, Patel's holding will rise to 2.77% from 2.29%.
About Gujarat Themis Biosyn Limited (GUJTHEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when GUJTHEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GUJTHEM — Free💡 Ask AI about this filing
📊 More GUJTHEM filings
- 🔴 Insider Trading — 15 July 2026 Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares...
- regulation 31 — 14 July 2026 Pharmaceutical Business Group (India) Limited disclosed an indirect encumbrance on its 47.02% stake ...
- Announcement — 13 July 2026 Gujarat Themis Biosyn Limited disclosed that it has amicably settled a commercial arbitration disput...
- share transfer — 10 July 2026 Gujarat Themis Biosyn Limited received a SEBI-mandated certificate from MUFG Intime India confirming...
- 🟡 Voting Results — 10 July 2026 Gujarat Themis Biosyn Limited announced voting results for special resolutions passed via e-voting o...
🔥 Also filed on 2 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when GUJTHEM files new disclosures
Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GUJTHEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research